Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Significant Scientific Agreement Standard Should Be "Flexible," Cmte. Says

This article was originally published in The Tan Sheet

Executive Summary

The significant scientific agreement standard used to determine the merit of a health claim should be "flexible," a final report by FDA's Food Advisory Committee Working Group on Significant Scientific Agreement/ Totality of Evidence states. The report was endorsed by the full committee at a meeting in Arlington, Va. June 25.

You may also be interested in...



Pearson v. Shalala

FDA's deadline to appeal the D.C. federal appeals court decision to the Supreme Court expires June 30 without action by the agency. The appeals court required the agency to clarify the definition of its "significant scientific agreement" standard for health claims and to consider whether the four health claims at issue in the case might be deemed appropriate with the use of labeled "disclaimers." The four claims pertain to antioxidants, fiber, omega-3 fatty acids and folic acid (1"The Tan Sheet" Jan. 25, p. 3). The agency's request for a rehearing of the case was denied (2"The Tan Sheet" April 5, p. 7)

Health Claims Research Tax Breaks Require Legislation - Food Cmte.

Incentives for industry-sponsored research on food or dietary supplement health claims such as exclusivity or tax breaks would be pursued best through the legislative process, the Research/Economic Incentives Working Group (IWG) of FDA's Food Advisory Committee suggests in a draft report on the issue. The draft was discussed and endorsed by the full FAC at a meeting in Arlington, Va. June 25.

Health Claims Research Tax Breaks Require Legislation - Food Cmte.

Incentives for industry-sponsored research on food or dietary supplement health claims such as exclusivity or tax breaks would be pursued best through the legislative process, the Research/Economic Incentives Working Group (IWG) of FDA's Food Advisory Committee suggests in a draft report on the issue. The draft was discussed and endorsed by the full FAC at a meeting in Arlington, Va. June 25.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090020

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel